At what percentage of blockage is stenting (percutaneous coronary intervention) typically considered during an angiogram?

Stenting During Coronary Angiogram: Percentage Thresholds for Intervention

Stenting is typically considered during coronary angiography when stenosis reaches 70% or greater in non-left main coronary arteries, or 50% or greater in the left main coronary artery, particularly when associated with symptoms or evidence of ischemia. 1

Stenosis Thresholds for Intervention

• Coronary lesions with ≥70% diameter stenosis in non-left main vessels are generally considered significant and may warrant intervention 1
• Left main coronary artery stenosis ≥50% is considered significant and may require revascularization 1
• For intermediate lesions (50-70% stenosis), Fractional Flow Reserve (FFR) assessment is recommended to determine physiological significance before proceeding with intervention 1

Role of Physiological Assessment in Intermediate Lesions

• FFR is reasonable to assess angiographically intermediate coronary lesions (50% to 70% diameter stenosis) to guide revascularization decisions 1
• An FFR value of ≤0.75 correlates with ischemia with high sensitivity (88%), specificity (100%), and overall accuracy (93%) 1
• Intravascular ultrasound (IVUS) is reasonable for evaluation of coronary obstruction at locations difficult to image by angiography in patients with suspected flow-limiting stenosis 1

Factors Beyond Stenosis Percentage That Influence Stenting Decisions

• Patient symptoms and quality of life despite optimal medical therapy 1
• Presence of viable myocardium at risk 1
• Lesion location (left main disease has a lower threshold for intervention) 1
• Lesion complexity and morphology 1
• Patient's ability to tolerate and comply with dual antiplatelet therapy (DAPT) 1
• Comorbidities and overall life expectancy 1

Clinical Outcomes Based on Intervention Strategy

• Stenting has demonstrated superior outcomes compared to balloon angioplasty alone:
  • Lower rates of restenosis (31.6% vs. 42.1%) 2
  • Larger luminal diameter at 6 months (1.74 mm vs. 1.56 mm) 2
  • Better clinical outcomes, particularly in proximal left anterior descending artery lesions 3
  • Reduced need for target vessel revascularization 4

Common Pitfalls and Caveats

• Angiography alone may under- or overestimate lesion severity, making physiologic assessment valuable for intermediate lesions 1
• Routine angiographic follow-up after stenting can lead to "oculostenotic reflex" - unnecessary treatment of non-ischemic intermediate lesions 5
• Stenting should be avoided when patients cannot comply with or tolerate the required duration of dual antiplatelet therapy 1
• The presence of coronary calcium may influence stent deployment success and should be assessed prior to intervention 1
• Patients with complex bifurcation lesions may require specialized stenting techniques 1

Special Considerations

• For patients with diabetes, drug-eluting stents (DES) are preferred over bare-metal stents (BMS) due to lower restenosis rates 1
• In high-risk anatomical locations such as unprotected left main disease, DES may be more appropriate due to lower rates of restenosis 1
• IVUS guidance during stent placement can improve outcomes by ensuring adequate stent expansion and apposition 1
• Patients with severe 3-vessel disease and reduced left ventricular function may be better candidates for coronary artery bypass grafting (CABG) than stenting 1